Covenant Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-28,340
| Closed | -$394K | – | 197 |
|
|
2024
Q1 | $394K | Buy |
+28,340
| New | +$394K | 0.11% | 117 |
|
|
2023
Q4 | – | Sell |
-40,015
| Closed | -$619K | – | 198 |
|
|
2023
Q3 | $619K | Sell |
40,015
-368
| -0.9% | -$5.69K | 0.22% | 77 |
|
|
2023
Q2 | $634K | Sell |
40,383
-3,357
| -8% | -$52.7K | 0.23% | 71 |
|
|
2023
Q1 | $721K | Sell |
43,740
-2,362
| -5% | -$38.9K | 0.28% | 58 |
|
|
2022
Q4 | $719K | Buy |
46,102
+2,362
| +5% | +$36.8K | 0.29% | 59 |
|
|
2022
Q3 | $567K | Sell |
43,740
-4,722
| -10% | -$61.2K | 0.28% | 68 |
|
|
2022
Q2 | $680K | Hold |
48,462
| – | – | 0.31% | 66 |
|
|
2022
Q1 | $694K | Buy |
48,462
+4,722
| +11% | +$67.6K | 0.28% | 77 |
|
|
2021
Q4 | $596K | Sell |
43,740
-1,493
| -3% | -$20.3K | 0.22% | 99 |
|
|
2021
Q3 | $741K | Buy |
45,233
+19,572
| +76% | +$321K | 0.29% | 74 |
|
|
2021
Q2 | $432K | Sell |
25,661
-28,637
| -53% | -$482K | 0.16% | 131 |
|
|
2021
Q1 | $991K | Sell |
54,298
-7,385
| -12% | -$135K | 0.39% | 47 |
|
|
2020
Q4 | $1.12M | Buy |
61,683
+13,157
| +27% | +$240K | 0.48% | 39 |
|
|
2020
Q3 | $866K | Sell |
48,526
-4,873
| -9% | -$87K | 0.42% | 52 |
|
|
2020
Q2 | $957K | Sell |
53,399
-14,891
| -22% | -$267K | 0.44% | 44 |
|
|
2020
Q1 | $1.04M | Sell |
68,290
-2,957
| -4% | -$44.9K | 0.55% | 26 |
|
|
2019
Q4 | $1.41M | Sell |
71,247
-3,960
| -5% | -$78.1K | 0.66% | 24 |
|
|
2019
Q3 | $1.29M | Buy |
75,207
+11,724
| +18% | +$202K | 0.69% | 27 |
|
|
2019
Q2 | $1.12M | Buy |
63,483
+4,480
| +8% | +$79.3K | 0.6% | 33 |
|
|
2019
Q1 | $1.2M | Buy |
59,003
+5,492
| +10% | +$112K | 0.67% | 22 |
|
|
2018
Q4 | $900K | Buy |
+53,511
| New | +$900K | 0.43% | 17 |
|